J&J’s Kenvue valued at $48 billion after shares jump in market debut
(Reuters) -Johnson & Johnson’s consumer health spinoff Kenvue Inc rose 16% and fetched a valuation of about $48 billion in its market debut on Thursday, marking the biggest U.S. initial public offering since 2021. Shares of the Listerine mouthwash maker debuted at $25.53 each, compared with their offer price of $22 apiece. J&J sold 172.8…
